Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma. [electronic resource]
Producer: 20070405Description: 279-83 p. digitalISSN:- 0268-3369
- Aged
- Aged, 80 and over
- Disease-Free Survival
- Female
- Follow-Up Studies
- Humans
- Male
- Melphalan -- administration & dosage
- Multiple Myeloma -- mortality
- Myeloablative Agonists -- administration & dosage
- Peripheral Blood Stem Cell Transplantation
- Retrospective Studies
- Survival Rate
- Transplantation, Autologous
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.